Roche
RO.SW
#44
Rank
NZ$610.39 B
Marketcap
NZ$766.10
Share price
-0.55%
Change (1 day)
36.30%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$36.20

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$36.20. In 2025 the company made an earnings per share (EPS) of NZ$36.20 an increase over its 2024 EPS that were of NZ$20.38.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$36.2077.67%
2024NZ$20.38-32.84%
2023NZ$30.341.95%
2022NZ$29.76-6.29%
2021NZ$31.75-5.53%
2020NZ$33.6116.56%
2019NZ$28.8430.3%
2018NZ$22.1320.22%
2017NZ$18.41-5.81%
2016NZ$19.544.62%
2015NZ$18.68-5.13%
2014NZ$19.69-25.05%
2013NZ$26.2721.73%
2012NZ$21.583.82%
2011NZ$20.798.16%
2010NZ$19.2223.72%
2009NZ$15.53-12.31%
2008NZ$17.71-0.34%
2007NZ$17.7832.13%
2006NZ$13.4542.56%
2005NZ$9.44-22.7%
2004NZ$12.21132.85%
2003NZ$5.24-151.22%
2002NZ-$10.24-209.09%
2001NZ$9.38-57.03%
2000NZ$21.8353.29%
1999NZ$14.2431.24%
1998NZ$10.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.47-57.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.80-67.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.52-84.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$28.73-20.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.37-90.69%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$6.38-82.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.24-93.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.66-84.35%๐Ÿ‡ฌ๐Ÿ‡ง UK